Fig. 1From: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical studyFlowchart of 238 women referred for [18F]FDG-PET/CT due to suspicion of first distant recurrent breast cancer, 2017–2019Back to article page